DexCom (NASDAQ:DXCM) Delivers Shareholders Decent 8.1% CAGR Over 5 Years, Surging 5.2% in the Last Week Alone

Simply Wall StJan 26 20:52

Should We Be Delighted With DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 34%?

Yahoo FinanceJan 25 21:00

Barclays Maintains DexCom(DXCM.US) With Hold Rating, Maintains Target Price $92

Futu NewsJan 22 16:33 · Ratings

Raymond James Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $99

Futu NewsJan 22 04:31 · Ratings

DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?

Zacks Jan 21 23:05

Barclays Maintains DexCom(DXCM.US) With Hold Rating, Cuts Target Price to $92

Futu NewsJan 21 20:31 · Ratings